TGF-β requires the activation of canonical and non-canonical signalling pathways to induce skeletal muscle atrophy

被引:47
作者
Abrigo, Johanna [2 ,3 ,4 ]
Campos, Fabian [2 ,3 ,4 ]
Simon, Felipe [2 ,3 ,4 ]
Riedel, Claudia [2 ,3 ,4 ]
Cabrera, Daniel [5 ,6 ]
Vilos, Cristian [7 ,8 ]
Cabello-Verrugio, Claudio [1 ,2 ,3 ,9 ]
机构
[1] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Lab Muscle Pathol Fragil & Aging, Ave Republ 239, Santiago 8370146, Chile
[2] Univ Andres Bello, Fac Med, Ave Republ 239, Santiago 8370146, Chile
[3] Millennium Inst Immunol & Immunotherapy, Santiago 8331150, Chile
[4] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Ave Republ 239, Santiago 8370146, Chile
[5] Univ Bernardo O Higgins, Fac Salud, Dept Ciencias Quim & Biol, Santiago 8370993, Chile
[6] Pontificia Univ Catolica Chile, Fac Med, Dept Gastroenterol, Santiago 8331150, Chile
[7] Univ Andres Bello, Fac Med, Ctr Integrat Med & Innovat Sci, Lab Nanomed & Targeted Delivery, Santiago 8370146, Chile
[8] Univ Andres Bello, Ctr Bioinformat & Integrat Biol, Fac Biol Sci, Santiago 8370146, Chile
[9] Univ Santiago Chile, Ctr Dev Nanosci & Nanotechnol CEDENNA, Santiago 9170022, Chile
关键词
MAPK; MuRF-1; muscle atrophy; reactive oxygen species; Smad; GROWTH-FACTOR-BETA; POLYMERASE CHAIN-REACTION; ANGIOTENSIN-II; PROTEIN-DEGRADATION; FIBROTIC RESPONSE; EXPRESSION; MECHANISMS; FIBROSIS; DECORIN; ALPHA;
D O I
10.1515/hsz-2017-0217
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transforming growth factor type-beta (TGF-beta) induces skeletal muscle atrophy characterised by a decrease in the fibre's diameter and levels of myosin heavy chain (MHC), also as an increase of MuRF-1 expression. In addition, TGF-beta induces muscle atrophy by a mechanism dependent on reactive oxygen species (ROS). TGF-beta signals by activating both canonical Smad-dependent, and non-canonical signalling pathways such as ERK1/2, JNK1/2, and p38 MAPKs. However, the participation of canonical and non-canonical signalling pathways in the TGF-beta atrophic effect on skeletal muscle is unknown. We evaluate the impact of Smad and MAPK signalling pathways on the TGF-beta-induced atrophic effect in C2C12 myotubes. The results indicate that TGF-beta activates Smad2/3, ERK1/2 and JNK1/2, but not p38 in myotubes. The pharmacological inhibition of Smad3, ERK1/2 and JNK1/2 activation completely abolished the atrophic effect of TGF-beta. Finally, the inhibition of these canonical and non-canonical pathways did not decrease the ROS increment, while the inhibition of ROS production entirely abolished the phosphorylation of Smad3, ERK1/2 and JNK1/2. These results suggest that TGF-beta requires Smad3, ERK1/2 and JNK1/2 activation to produce skeletal muscle atrophy. Moreover, the induction of ROS by TGF-beta is an upstream event to canonical and non-canonical pathways.
引用
收藏
页码:253 / 264
页数:12
相关论文
共 49 条
[1]   Transforming growth factor type beta (TGF-β) requires reactive oxygen species to induce skeletal muscle atrophy [J].
Abrigo, Johanna ;
Carlos Rivera, Juan ;
Simon, Felipe ;
Cabrera, Daniel ;
Cabello-Verrugio, Claudio .
CELLULAR SIGNALLING, 2016, 28 (05) :366-376
[2]   Apocynin inhibits the upregulation of TGF-β1 expression and ROS production induced by TGF-β in skeletal muscle cells [J].
Abrigo, Johanna ;
Gabriela Morales, Maria ;
Simon, Felipe ;
Cabrera, Daniel ;
Di Capua, Gabriella ;
Cabello-Verrugio, Claudio .
PHYTOMEDICINE, 2015, 22 (10) :885-893
[3]  
Argilés JM, 2011, SARCOPENIA-AGE-RELATED MUSCLE WASTING AND WEAKNESS: MECHANISMS AND TREATMENTS, P9, DOI 10.1007/978-90-481-9713-2_2
[4]  
Barbieri Elena, 2012, J Signal Transduct, V2012, P982794, DOI 10.1155/2012/982794
[5]   SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[6]   Transforming growth factor-β1 and fibrosis in congenital muscular dystrophies [J].
Bernasconi, P ;
Di Blasi, C ;
Mora, M ;
Morandi, L ;
Galbiati, S ;
Confalonieri, P ;
Cornelio, F ;
Mantegazza, R .
NEUROMUSCULAR DISORDERS, 1999, 9 (01) :28-33
[7]   Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy [J].
Brandan, Enrique ;
Cabello-Verrugio, Claudio ;
Vial, Cecilia .
MATRIX BIOLOGY, 2008, 27 (08) :700-708
[8]   Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I [J].
Brink, M ;
Price, SR ;
Chrast, J ;
Bailey, JL ;
Anwar, A ;
Mitch, WE ;
Delafontaine, P .
ENDOCRINOLOGY, 2001, 142 (04) :1489-1496
[9]   Role of TGF-β signaling in inherited and acquired myopathies [J].
Burks, Tyesha N. ;
Cohn, Ronald D. .
SKELETAL MUSCLE, 2011, 1
[10]   Losartan Restores Skeletal Muscle Remodeling and Protects Against Disuse Atrophy in Sarcopenia [J].
Burks, Tyesha N. ;
Andres-Mateos, Eva ;
Marx, Ruth ;
Mejias, Rebeca ;
Van Erp, Christel ;
Simmers, Jessica L. ;
Walston, Jeremy D. ;
Ward, Christopher W. ;
Cohn, Ronald D. .
SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (82)